September/October

With American Patients First, the administration is doing its part to improve prescription drug affordability—now it’s time for Congress to do theirs.

The FDA recently launched one of its first programs following the release of the Trump administration’s new drug price plan.

For payers, employers, and health systems, spending on specialty medications and the spending trend remain common concerns.

The inhibition of the tumor necrosis factor alpha (TNF-α) pathway and its proinflammatory processes has been central in psoriasis management.

As specialty spending continues to creep up to 50% of total drug spend, payers have an option to directly reduce their costs while impacting a relatively small volume of prescriptions.

By establishing in-house specialty pharmacies, health systems can accelerate growth while offering patients innovative therapies, an enhanced experience, and clinically coordinated care that ultimately improves outcomes.

There has been increasing buzz surrounding health care reform concepts that which seek to address the singular issue of individual health care coverage affordability.

Earning the CSP credential demonstrates a commitment to practice excellence and provides lifelong learning and growth within the specialty pharmacy industry and is a key indicator to employers, manufacturers, patients, payers, other health care providers, and the public that a professional is an expert in specialty pharmaceuticals.

There is no doubt that aggressive actions must be taken throughout the US health care landscape to rein in spending on prescription drugs and help patients to access lifesaving therapies.

Genetic discrimination occurs when people are treated differently by their employer or insurance company because they have a genetic mutation that causes or increases the risk of an inherited disorder or they have a familial history of a specific health condition.

USP Chapter presents many challenges for pharmacies and other health care settings, especially compounding pharmacies.

Given the state of political affairs currently engulfing health care, our industry regularly gets vilified and is frequently a victim of misperception.